Cytokinetics Inc (CYTK)

Total asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	7,530	7,815	9,952	95,246	91,781	141,206	139,967	56,649	58,061	9,383	45,819	46,569	47,834	47,611	14,609	16,776	20,245	23,344	29,275	29,730
Total assets	US$ in thousands	824,316	740,614	779,899	889,815	1,014,780	1,075,960	771,717	856,253	841,319	827,539	564,302	577,062	533,803	474,112	232,495	256,582	289,814	187,393	198,218	198,611
Total asset turnover		0.01	0.01	0.01	0.11	0.09	0.13	0.18	0.07	0.07	0.01	0.08	0.08	0.09	0.10	0.06	0.07	0.07	0.12	0.15	0.15

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $7,530K ÷ $824,316K
= 0.01

The total asset turnover ratio for Cytokinetics Inc has shown fluctuations over the past eight quarters. In the most recent quarter, Q4 2023, the total asset turnover ratio was 0.01, indicating that the company generated $0.01 in revenue for every dollar of total assets. This ratio has remained relatively low and consistent over the past four quarters, suggesting inefficiency in the utilization of assets to generate revenue.

However, in Q3 2022, there was a significant increase in the total asset turnover ratio to 0.14, which then further increased to 0.20 in Q2 2022. These higher ratios suggest that the company was more effective in generating revenue from its total assets during that period.

Overall, the trend in Cytokinetics Inc's total asset turnover indicates a need for improvement in efficiently utilizing its assets to generate revenue. It is important for the company to assess and address the factors contributing to the lower turnover ratios in recent quarters to enhance its operational efficiency and profitability.